PENTIXAPHARM HOLDING N AG
Research PENTIXAPHARM HOLDING N AG (PTP) on Bullrun: market cap EUR 52.04M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPTP
- ExchangeXETRA
- CountryGermany
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 52.04M
- Financial periodQ4 2025
- Revenue-EUR 24.00K
- Net income-EUR 3.82M
- Free cash flow-EUR 2.35M
- Gross margin8737.5%
Valuation Snapshot
latest market cap is EUR 52.04M.
About PENTIXAPHARM HOLDING N AG
Pentixapharm Holding AG, a clinical-stage biopharmaceutical company, develops radiopharmaceuticals. The company focuses on developing CXCR4 binding, peptide-based technology, which includes PentixaFor (PT-001), a tracer based on Gallium-68, used to diagnose and monitor the progress of various diseases, including hematological and solid tumors, as well as endocrine, cardiovascular, and immunological disorders;
Frequently asked questions
What is PENTIXAPHARM HOLDING N AG's market cap?
PENTIXAPHARM HOLDING N AG's market capitalization is EUR 52.04M.
What does PENTIXAPHARM HOLDING N AG do?
Pentixapharm Holding AG, a clinical-stage biopharmaceutical company, develops radiopharmaceuticals. The company focuses on developing CXCR4 binding, peptide-based technology, which includes PentixaFor (PT-001), a tracer based on Gallium-68, used to diagnose and monitor the progress of various...